Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis.
about
Erlotinib for advanced pancreatic cancerImaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted NanovesiclesDocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis.Effects of arginine-glycine-aspartic acid peptide-conjugated quantum dots-induced photodynamic therapy on pancreatic carcinoma in vivo.Use of gemcitabine as a second-line treatment following chemotherapy with folfirinox for metastatic pancreatic adenocarcinomaPancreatic cancer genomics: where can the science take us?Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: a single institutional experienceSU11274 suppresses proliferation and motility of pancreatic cancer cells.Phase II clinical trials on investigational drugs for the treatment of pancreatic cancersMacrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines.Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer.Meta-analyses of treatment standards for pancreatic cancer.Epidemiology Characteristics, Methodological Assessment and Reporting of Statistical Analysis of Network Meta-Analyses in the Field of Cancer.Nanoformulations for therapy of pancreatic and liver cancers.The lymphatic system and pancreatic cancer.Knockdown delta-5-desaturase promotes the formation of a novel free radical byproduct from COX-catalyzed ω-6 peroxidation to induce apoptosis and sensitize pancreatic cancer cells to chemotherapy drugs.Safety of palliative chemotherapy in advanced pancreatic cancer.Replication-competent adenoviruses with the type 35-derived fiber-knob region achieve reactive oxygen species-dependent cytotoxicity and produce greater toxicity than those with the type 5-derived region in pancreatic carcinoma.Surgical strategies and novel therapies for locally advanced pancreatic cancer.Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: results of the PANCOSTABRAX study.Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma.1-Pamitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol May Reduce Incidence of Gemcitabine-Induced Neutropenia: A Pilot Case-Controlled Study.Clinical Trials in Pancreatic Cancer: A Long Slog."HEATPAC" - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer.A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers.Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study.Defects in homologous recombination repair genes are associated with good prognosis and clinical sensitivity to DNA-damaging agents in pancreatic cancer: A case report.The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis.
P2860
Q24186983-34A390D3-AD49-40D0-B800-ECD81BDB49B1Q26828959-B138492D-120E-4AF6-AB6D-AFE5F84AB274Q30315797-3F4C5665-5BCE-4A16-AA43-CE9BCFF3714CQ33421322-6D1FB073-94A0-462F-8BE1-71B43909E56AQ33442676-7641FA4D-B20A-4A7B-8C4E-0C912BB2B566Q33553685-FDE94BAE-29C6-41D6-9287-05764C39473FQ33751227-9A40A4AF-E4BB-440B-A842-D1B4BD38635DQ34447458-B0EBA45D-FCB1-483F-ADA6-502BF966BB90Q34537580-519E4241-7F2E-40B6-839E-B5C31A262846Q35781556-12446882-FB2E-4622-B701-EB3CBC73670AQ35944581-5D5D831D-ED63-4584-B7E4-68401686282AQ36384541-A176C821-BA3A-4FF4-99A7-D92B3AB2527EQ36525403-693D1338-1D12-48A6-8634-3E8CEAF14725Q36563900-3D9D1DCE-BD0B-459C-A2EC-29E60BA5BF2EQ36640493-893B5F6B-03DE-4531-BC24-978155F80E83Q37416900-5184E9D6-8C25-449A-AF2E-63C5097C9FBDQ38495105-58742FB9-4248-4CF3-AC0D-1211B0C54604Q38689578-9E49CA37-1FB8-4974-B4D4-6E06AB887B31Q38760434-EC4328D8-2C66-4A56-B8C2-A8FDDA9BE70DQ38806041-46221EFD-D071-4A36-8F8B-B085DABFCA7BQ38835086-D0085F01-00E4-4AEA-9176-818EE9D21129Q39312912-DA062332-11E5-4F4F-B4A5-C503B0C49DA5Q40922213-153B0ED7-0219-4D77-8D43-D5717B767AFBQ41598639-5DA1D5CE-0C34-4CA4-BDE0-3E4B9AF14499Q41958401-FD2CA808-B1ED-4F39-A1AD-4C2ADF4C2F9DQ47095955-78B3A807-D8E0-47AA-8CD7-750A0A8C91B5Q47107002-84C2DC44-5610-45BF-9110-1BB015A528BBQ48293161-92C28197-882B-4B4C-BF98-8FADD04F64A6Q50271158-7815CAE3-8F4A-490E-9E8F-221339293818Q54112415-FF94843C-BFD6-4DB7-B910-1A47A7C87739Q55381776-FC123A7E-FF9D-4082-AF39-BD8C16224539
P2860
Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chemotherapy regimens for adva ...... iew and network meta-analysis.
@ast
Chemotherapy regimens for adva ...... iew and network meta-analysis.
@en
type
label
Chemotherapy regimens for adva ...... iew and network meta-analysis.
@ast
Chemotherapy regimens for adva ...... iew and network meta-analysis.
@en
prefLabel
Chemotherapy regimens for adva ...... iew and network meta-analysis.
@ast
Chemotherapy regimens for adva ...... iew and network meta-analysis.
@en
P2093
P2860
P31
P921
P356
P1433
P1476
Chemotherapy regimens for adva ...... iew and network meta-analysis.
@en
P2093
Christopher Cameron
Derek J Jonker
George A Wells
Gillian K Gresham
Sharlene Gill
P2860
P2888
P356
10.1186/1471-2407-14-471
P407
P5008
P577
2014-06-27T00:00:00Z
P5875
P6179
1026098787